What are the differential diagnoses for a 53‑year‑old woman with left shoulder pain radiating to the clavicular area and a tender 6 × 5 cm sub‑clavicular mass, given her history of stage IIIA invasive ductal carcinoma treated with modified radical mastectomy, chemoradiation, ongoing letrozole therapy, hypertension, chronic hepatitis B, and recent NSAID use?

Differential Diagnoses for Left Shoulder Pain with Subclavicular Mass in Post-Breast Cancer Patient

The most critical differential diagnosis in this patient is locoregional breast cancer recurrence or metastasis, given her stage IIIA invasive ductal carcinoma history, the presence of a tender 6×5 cm subclavicular mass, and severe pain radiating to the clavicular area. This requires urgent imaging and tissue diagnosis to rule out malignancy before attributing symptoms to benign musculoskeletal causes.

Primary Differential Diagnoses (Ranked by Clinical Priority)

1. Locoregional Breast Cancer Recurrence/Metastasis (HIGHEST PRIORITY)

• Clinical reasoning: Stage IIIA breast cancer s/p MRM (2019) with chemoradiation places her at significant risk for locoregional recurrence, particularly in the supraclavicular/infraclavicular nodal regions 1
• Key features supporting this:
  • Palpable 6×5 cm tender subclavicular mass (new finding)
  • Pain severity (10/10) unresponsive to multiple NSAIDs
  • Pain aggravated by neck movement (suggests mass effect on neurovascular structures)
  • Currently on letrozole (indicating hormone receptor-positive disease with ongoing systemic risk)
• Critical action: This mass represents a potential regional nodal recurrence in the infraclavicular/supraclavicular region, which was part of her original stage IIIA disease burden 1

2. Bone Metastasis to Clavicle

• Clinical reasoning: Clavicular lesions in breast cancer patients carry 50% risk of malignancy when metastatic disease is considered 2
• Supporting features:
  • Severe localized bone pain (10/10)
  • History of invasive ductal carcinoma
  • Age 53 (advancing age increases malignancy risk in clavicular lesions) 2
  • Medial clavicular involvement most common site for pathology (73% of cases) 2

3. Musculoskeletal Strain/Rotator Cuff Pathology

• Clinical reasoning: Common cause of acute shoulder pain, but less likely given the palpable mass 3
• Features that would support this:
  • Pain aggravated by movement
  • Recent NSAID use with partial response
• Features AGAINST this diagnosis:
  • Presence of discrete 6×5 cm mass (not typical for simple strain)
  • Severity of pain (10/10) despite multiple analgesics
  • No history of trauma

4. Inflammatory/Crystalline Arthropathy

• Clinical reasoning: Recent right knee monoarthritis treated as presumed gout raises possibility of polyarticular crystal disease
• Features supporting:
  • Recent episode of joint pain/swelling (right knee) responsive to colchicine
  • Sternoclavicular joint involvement can occur in rheumatoid arthritis and mimic malignancy 4
• Features AGAINST:
  • Discrete soft tissue mass (not typical for crystalline arthropathy)
  • No systemic inflammatory symptoms
  • Unilateral presentation

5. Infection (Osteomyelitis/Septic Arthritis)

• Clinical reasoning: Infection is the most common clavicular pathology overall (39% of cases), especially in patients <20 years, but less common in this age group 2
• Features AGAINST:
  • Afebrile (36.9°C)
  • No constitutional symptoms
  • Chronic Hepatitis B on treatment (not acutely immunocompromised)
  • Important caveat: ESR and CRP have poor predictive value for clavicular osteomyelitis 2, so normal inflammatory markers do NOT exclude infection

6. Letrozole-Related Musculoskeletal Toxicity

• Clinical reasoning: Aromatase inhibitors cause musculoskeletal pain in 21-22% of patients 5
• Features supporting:
  • Currently on letrozole
  • Musculoskeletal pain is common adverse effect
• Features AGAINST:
  • Discrete palpable mass (not explained by drug toxicity)
  • Severity and localization atypical for AI-related arthralgia

Critical Red Flags Present in This Case

• Palpable 6×5 cm subclavicular mass (new finding, not previously documented)
• History of stage IIIA breast cancer (high-risk for locoregional recurrence)
• Severe pain (10/10) refractory to multiple NSAIDs
• Pain radiating to clavicular area (suggests involvement of neurovascular structures or bone)
• Location in infraclavicular/supraclavicular region (classic site for breast cancer nodal recurrence) 1

Immediate Diagnostic Workup Required

Imaging priority:

1. MRI of the left shoulder/chest wall with contrast - MRI has high sensitivity and specificity for identifying nature of clavicular lesions and should be considered in ALL clavicular pathology cases 2
2. CT chest/abdomen/pelvis with contrast - For systemic staging if malignancy suspected 1
3. Bone scan or PET/CT - To evaluate for distant metastases 1

Tissue diagnosis:

• Core needle biopsy or excisional biopsy of subclavicular mass - Essential for definitive diagnosis, especially given history of breast cancer 2, 4

Laboratory:

• Complete blood count, comprehensive metabolic panel
• Tumor markers (CA 15-3, CA 27-29) if not recently checked
• Note: Do NOT rely on ESR/CRP to exclude infection in clavicular lesions 2

Common Pitfalls to Avoid

1. Attributing pain to simple musculoskeletal strain without investigating the palpable mass - This is the most dangerous error in this case 6
2. Assuming letrozole-related arthralgia explains a discrete mass - AI toxicity causes diffuse joint pain, not focal masses 5
3. Delaying imaging because inflammatory markers are normal - ESR/CRP have poor sensitivity for clavicular pathology 2
4. Treating empirically with more analgesics without tissue diagnosis - Given cancer history, this represents a critical delay in diagnosis 7, 6

This patient requires urgent multidisciplinary evaluation including medical oncology, surgical oncology, and radiology, with MRI and tissue biopsy as first-line diagnostic steps before any further symptomatic treatment.